Normal infant after treatment of acute myeloid leukaemia in pregnancy with daunorubicin.
Aust N Z J Med
; 8(4): 431-2, 1978 Aug.
Article
em En
| MEDLINE
| ID: mdl-282860
ABSTRACT
Daunorubicin, thioguanine and cytosine arabinoside were administered from the 17th to 34th weeks of pregnancy in a 23-year-old patient with acute myeloid leukaemia. The patient went into remission of her leukaemia, and a normal male infant was born after labour was induced in the 40th week. This experience supports the view that modern regimens of anti-leukaemic drugs may be administered during the second and third trimesters of pregnancy without harmful effects on the foetus.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Complicações Hematológicas na Gravidez
/
Leucemia Mieloide Aguda
/
Daunorrubicina
/
Feto
Limite:
Adult
/
Female
/
Humans
/
Male
/
Newborn
/
Pregnancy
Idioma:
En
Revista:
Aust N Z J Med
Ano de publicação:
1978
Tipo de documento:
Article